IP Library Granted Patent US 8,962,040
Granted Patent B2
US 8,962,040 · App. 13/653,320 · Granted Feb 24, 2015

Vaporized medicants and methods of use

Inventors: Alexander ChinHak Chong (St. Louis Park, MN); William Bartkowski (Edina, MN); Marshall Thompson (Camarillo, CA)
A61K36/34A61K47/10A61K9/0078A61K47/26Y10S514/958
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,962,040
App. No.
13/653,320
Granted
Feb 24, 2015
Kind
B2
Abstract

A method and formulation for delivering an active compound in a vaporized state using low temperatures to vaporize the formulation. The formulation contains an inert non-reactive compound that lowers the heat of vaporization of the formulation, and the active compound. The formulation may optionally contain glycerin, alcohol, and/or water. Examples of inert non-reactive compounds that can sufficiently lower the heat of vaporization of the formulation include propylene glycol and polysorbate. The formulation can be vaporized using a hand-held low temperature vaporizer or atomizer.

Claims (12)

1. A method for delivering medicants through inhalation, comprising:

a. acquiring a medicant solution suitable for vaporization at a low temperature, the medicant solution, comprising:

i. an inert non-reactive compound, and

ii. hoodia; and

b. vaporizing the medicant solution at the low temperature such that an effective serving of the hoodia is provided to the user for inhalation, wherein the low temperature is from approximately 90 degrees C. to approximately 250 degrees C.

2. The method of claim 1 , wherein the step of vaporizing the medic solution comprises using a low temperature vaporizer.

3. The method of claim 1 , wherein the medicant solution further comprises approximately 0.01% to approximately 30% of water.

4. The method of claim 1 , wherein the medicant solution further comprises approximately 0.01% to approximately 30% of alcohol.

5. The method of claim 1 , wherein the inert non-reactive compound comprises polysorbate.

6. The method of claim 1 , wherein the low temperature is from approximately 90 degrees C. to approximately 200 degrees C.

7. The method of claim 1 , wherein the low temperature is from approximately 100 degrees C. to approximately 160 degrees C.

8. The method of claim 1 , wherein the low temperature is from approximately 110 degrees C. to approximately 140 degrees C.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2020
From: XTEN CAPITAL GROUP, INC.
To: CQENS TECHNOLOGIES, INC.
Reel/Frame 054143/0130 →
CHANGE OF NAME Recorded Apr 23, 2020
From: CHONG CORPORATION
To: XTEN CAPITAL GROUP, INC.
Reel/Frame 052484/0850 →
Continuity (3)
Continuation In Part 12858382 · Aug 17, 2010
Provisional Application 61234562 · Aug 17, 2009
Related Publication 20130072577A1 · Mar 21, 2013